Timothy P. Clackson - 17 Jun 2022 Form 4 Insider Report for Elevation Oncology, Inc. (ELEV)

Role: Director
Signature: /s/ Tammy Furlong, Attorney-in-Fact
Issuer symbol: ELEV
Transactions as of: 17 Jun 2022
Net transactions value: $0
Form type: 4
Filing time: 22 Jun 2022, 18:42:20 UTC
Previous filing: 09 Jun 2022
Next filing: 14 Oct 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELEV	Common Stock	Gift	$0	-31,553	-67%	$0.000000	15,777	31 May 2022	Direct	F1
holding	ELEV	Common Stock						31,553	17 Jun 2022	The Timothy P. Clackson Irrevocable GST Trust of 2020

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ELEV	Stock Option (Right to Buy)	Award	$0	+15,619		$0.000000	15,619	17 Jun 2022	Common Stock	15,619	$1.31	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On May 31, 2022, the reporting person transferred 31,553 shares of the Issuer's Common Stock to The Timothy P. Clackson Irrevocable GST Trust of 2020, of which the reporting person is trustee. The reporting person and members of his immediate family are the sole beneficiaries of the trust.
F2	The stock option vests as to 100% of the total shares on the one year anniversary of the grant date, subject to the Reporting Person's provision of service to the Issuer on such vesting date.